|
WO2002008288A2
(fr)
*
|
2000-07-20 |
2002-01-31 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
|
|
WO2002018435A1
(fr)
*
|
2000-08-28 |
2002-03-07 |
Human Genome Sciences, Inc. |
18 protéines humaines sécrétées
|
|
US20020137890A1
(en)
|
1997-03-31 |
2002-09-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US6706262B1
(en)
|
1998-03-18 |
2004-03-16 |
Corixa Corporation |
Compounds and methods for therapy and diagnosis of lung cancer
|
|
US7258860B2
(en)
|
1998-03-18 |
2007-08-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US6960570B2
(en)
|
1998-03-18 |
2005-11-01 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
|
US7579160B2
(en)
|
1998-03-18 |
2009-08-25 |
Corixa Corporation |
Methods for the detection of cervical cancer
|
|
EP2333069A3
(fr)
|
1998-05-15 |
2011-09-14 |
Genentech, Inc. |
Utilisations therapeutiques de polypeptides homologues de il-17
|
|
US7771719B1
(en)
|
2000-01-11 |
2010-08-10 |
Genentech, Inc. |
Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
|
|
US6929938B2
(en)
|
2001-08-15 |
2005-08-16 |
Millennium Pharmaceuticals, Inc. |
25501, a human transferase family member and uses therefor
|
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
|
EP1163252A4
(fr)
*
|
1999-02-25 |
2004-04-07 |
Univ Jefferson |
Compositions, kits et procedes concernant le gene fez1 de l'homme, nouveau gene suppresseur des tumeurs
|
|
EP1157038A4
(fr)
*
|
1999-02-26 |
2005-01-19 |
Smithkline Beecham Corp |
Clonage du recepteur 7tm (axor 17) du type p2y
|
|
EP1169440A4
(fr)
*
|
1999-03-23 |
2004-01-14 |
Human Genome Sciences Inc |
48 proteines humaines secretees
|
|
EP1174509A4
(fr)
*
|
1999-03-29 |
2003-10-22 |
Kansai Tech Licensing Org Co |
Nouvelle cytidine desaminase
|
|
EP1621620A3
(fr)
*
|
1999-09-01 |
2006-05-10 |
Genetech, Inc. |
Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci
|
|
WO2001030971A2
(fr)
*
|
1999-10-27 |
2001-05-03 |
Millennium Pharmaceuticals, Inc. |
Nouvelles molecules de la famille des proteines se rapportant aux card et leurs utilisations
|
|
US6893818B1
(en)
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
|
US7005499B1
(en)
*
|
1999-11-18 |
2006-02-28 |
Genentech, Inc. |
Wnt-regulated cytokine-like polypeptide and nucleic acids encoding same
|
|
EP1878794A3
(fr)
*
|
1999-11-30 |
2008-01-23 |
Genentech, Inc. |
Compositions et procédés pour le traitement de maladies liées au système immunitaire
|
|
CA2492049A1
(fr)
*
|
1999-12-01 |
2001-06-07 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant ces polypeptides
|
|
CN1300781A
(zh)
*
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
一种新的多肽-人shc蛋白43和编码这种多肽的多核苷酸
|
|
US20040043397A1
(en)
|
2000-01-11 |
2004-03-04 |
Genentech, Inc. |
IL-17 homologous polypeptides and therapeutic uses thereof
|
|
DK1967586T3
(da)
|
2000-01-26 |
2011-06-20 |
Agensys Inc |
84P2A9: prostata- og testikelspecifikt protein med høj ekspression ved prostatacancer
|
|
US6953682B2
(en)
|
2000-02-10 |
2005-10-11 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding adenylate kinase, phospholipid scramblase-like, DNA fragmentation factor-like, phosphatidylserine synthase-like, and atpase-like molecules and uses therefor
|
|
US20020082212A1
(en)
*
|
2000-07-20 |
2002-06-27 |
Millennium Pharmaceuticals, Inc. |
7716, a novel human ATPase and uses therefor
|
|
US7078205B2
(en)
|
2000-02-17 |
2006-07-18 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, atpase molecules, acyltransferase molecules, pyridoxal-phosphate dependent enzyme molecules and uses therefor
|
|
US20020031815A1
(en)
*
|
2000-06-26 |
2002-03-14 |
Millennium Pharmaceuticals, Inc. |
46619, a novel human beta-ketoacyl synthase and uses thereof
|
|
US20020090705A1
(en)
*
|
2000-07-14 |
2002-07-11 |
Rachel Meyers |
62088, a novel human nucleoside phosphatase family member and uses thereof
|
|
US7718397B2
(en)
|
2000-03-21 |
2010-05-18 |
Genentech, Inc. |
Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
|
|
AU2001250980A1
(en)
*
|
2000-03-23 |
2001-10-03 |
Carmela Beger |
Brca-1 regulators and methods of use
|
|
AU2001245974A1
(en)
|
2000-03-24 |
2001-10-08 |
Millennium Pharmaceuticals, Inc. |
3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
|
|
US20030198953A1
(en)
*
|
2000-03-30 |
2003-10-23 |
Spytek Kimberly A. |
Novel proteins and nucleic acids encoding same
|
|
US7632929B2
(en)
|
2000-04-20 |
2009-12-15 |
The Board Of Trustees Of The University Of Arkansas |
Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
|
|
AU2001257195B2
(en)
|
2000-04-25 |
2006-10-05 |
Lexicon Pharmaceuticals, Inc. |
Novel human kinase proteins and polynucleotides encoding the same
|
|
WO2001081586A2
(fr)
*
|
2000-04-26 |
2001-11-01 |
Millennium Pharmaceuticals, Inc. |
21657, deshydrogenase humaine a chaine courte et ses utilisations
|
|
US6808876B1
(en)
*
|
2000-05-02 |
2004-10-26 |
Immusol, Inc. |
Cellular regulators of infectious agents and methods of use
|
|
CA2408828A1
(fr)
*
|
2000-05-12 |
2001-11-15 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Nouvelle serine-threonine kinase-4
|
|
WO2001090160A2
(fr)
*
|
2000-05-26 |
2001-11-29 |
Bayer Aktiengesellschaft |
Regulation de la serine/threonine kinase humaine analogue a p78
|
|
EP1158001B1
(fr)
*
|
2000-05-26 |
2007-11-14 |
F. Hoffmann-La Roche Ag |
Un acide nucléique produit excessivement dans des cellules tumorales humaines, une protéine codée par ledit acide nucléique et un procédé de diagnose de tumeurs
|
|
DE10027170A1
(de)
*
|
2000-05-31 |
2001-12-13 |
Schering Ag |
Humanes PEM als Target für die Fertilitätskontrolle
|
|
US7098311B2
(en)
*
|
2000-06-02 |
2006-08-29 |
Brigham And Women's Hospital |
Fusion of jAZF1 and jjAZ1 genes in endometrial stromal tumors
|
|
AU6531101A
(en)
*
|
2000-06-02 |
2001-12-17 |
Genentech Inc |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
US20030096969A1
(en)
|
2000-06-02 |
2003-05-22 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
|
WO2001094385A2
(fr)
*
|
2000-06-05 |
2001-12-13 |
Bayer Aktiengesellschaft |
Regulation du recepteur couple a la proteine humaine g de type hm74
|
|
US6323016B1
(en)
|
2000-06-09 |
2001-11-27 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
AU2001269766A1
(en)
*
|
2000-06-09 |
2001-12-24 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
|
AU2001268435A1
(en)
*
|
2000-06-15 |
2001-12-24 |
Millennium Pharmaceuticals, Inc. |
23680, a novel human aminotransferase and uses therefor
|
|
AU2001269888A1
(en)
*
|
2000-06-16 |
2001-12-24 |
Incyte Genomics, Inc. |
Protein phosphatases
|
|
CA2709771A1
(fr)
*
|
2000-06-23 |
2002-01-03 |
Genentech, Inc. |
Compositions et methode de diagnostic et de traitement des troubles mettant en cause l'angiogenese
|
|
WO2002000691A2
(fr)
*
|
2000-06-27 |
2002-01-03 |
Curagen Corporation |
Nouveaux polynucleotides et polypeptides codes par ceux-ci
|
|
US7094587B2
(en)
|
2000-06-27 |
2006-08-22 |
Millennium Pharmaceuticals, Inc. |
16002 Molecules and uses therefor
|
|
US6774223B2
(en)
|
2000-06-28 |
2004-08-10 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating colon cancer
|
|
WO2002002761A2
(fr)
*
|
2000-06-30 |
2002-01-10 |
Millennium Pharmaceuticals, Inc. |
57658, nouvelle uridine kinase humaine et utilisations correspondantes
|
|
AU2001273239A1
(en)
*
|
2000-07-07 |
2002-01-21 |
Incyte Genomics, Inc. |
Transporters and ion channels
|
|
WO2002004510A2
(fr)
*
|
2000-07-07 |
2002-01-17 |
Incyte Genomics, Inc. |
Proteines liant le nucleotide guanine
|
|
US6740751B2
(en)
|
2000-07-18 |
2004-05-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for stabilizing microtubules and intermediate filaments in striated muscle cells
|
|
WO2002006453A2
(fr)
*
|
2000-07-18 |
2002-01-24 |
Bayer Aktiengesellschaft |
Regulation de protease a serine humaine de type desc1
|
|
AU8762901A
(en)
*
|
2000-07-25 |
2002-02-05 |
Merck Patent Gmbh |
Novel protein containing ring finger domaine r1p4
|
|
AU2001277202A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-ras/rerg protein and related reagents and methods of use thereof
|
|
AU2001277200A1
(en)
*
|
2000-07-26 |
2002-02-05 |
Applied Genomics, Inc. |
Bstp-cad protein and related reagents and methods of use thereof
|
|
US7335732B2
(en)
|
2000-08-01 |
2008-02-26 |
Genentech, Inc. |
PRO9799 polypeptides
|
|
EP1657254A3
(fr)
*
|
2000-08-01 |
2006-06-07 |
Genentech, Inc. |
Polypeptide, acides nucléiques le codant, et leur utilisation pour le diagnostic du cancer
|
|
EP1315431A1
(fr)
*
|
2000-08-02 |
2003-06-04 |
Millennium Pharmaceuticals, Inc. |
Membre de la famille du facteur de liberation du gtp humain (15368) et ses utilisations
|
|
EP1307557A2
(fr)
|
2000-08-02 |
2003-05-07 |
The Johns Hopkins University |
Profils d'expression de cellules endotheliales
|
|
WO2002012330A2
(fr)
*
|
2000-08-04 |
2002-02-14 |
Zymogenetics, Inc. |
Zzp1, proteine humaine secretee
|
|
WO2002012285A2
(fr)
|
2000-08-10 |
2002-02-14 |
Board Of Regents, The University Of Texas System |
Suppresseur de tumeur car-1
|
|
CA2418266A1
(fr)
*
|
2000-08-11 |
2002-02-21 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Nouvelles proteines mekk
|
|
EP1326985A1
(fr)
*
|
2000-08-18 |
2003-07-16 |
MERCK PATENT GmbH |
Identification d'un gene d'acetyltransferase n-terminale humaine
|
|
WO2002016587A2
(fr)
*
|
2000-08-21 |
2002-02-28 |
Incyte Genomics, Inc. |
Proteines associees aux microtubules et tubulines
|
|
US6706513B2
(en)
|
2000-08-21 |
2004-03-16 |
Bristol-Myers Squibb Company |
Adenosine deaminase homolog
|
|
AU2001284655A1
(en)
*
|
2000-08-24 |
2002-03-04 |
Eli Lilly And Company |
Nucleic acids, vectors, host cells, polypeptides and uses thereof
|
|
WO2002018568A2
(fr)
*
|
2000-08-28 |
2002-03-07 |
Astrazeneca Ab |
Molecules
|
|
US7217799B2
(en)
|
2000-08-28 |
2007-05-15 |
Agensys, Inc. |
Antibodies that recognize the 85P1B3 protein useful in treatment and detection of cancer
|
|
AU2001285908A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
|
US20020091238A1
(en)
*
|
2000-08-30 |
2002-07-11 |
Curtis Rory A.J. |
54370, a novel human sulfate transporter and uses therefor
|
|
WO2002018577A2
(fr)
*
|
2000-08-30 |
2002-03-07 |
Millennium Pharmaceuticals, Inc. |
Nouveau facteur de terminaison du gtp humain 48921 et ses utilisations
|
|
AU2002210464A1
(en)
*
|
2000-08-30 |
2002-03-13 |
Bayer Aktiengesellschaft |
Regulation of human aminotransferase-like enzyme
|
|
WO2002018582A2
(fr)
*
|
2000-08-31 |
2002-03-07 |
Millennium Pharmaceuticals, Inc. |
62112, nouvelle deshydrogenase humaine et ses utilisations
|
|
WO2002020754A2
(fr)
*
|
2000-09-05 |
2002-03-14 |
Incyte Genomics, Inc. |
Molecules utilisees a des fins diagnostiques et therapeutiques
|
|
CA2421588C
(fr)
|
2000-09-05 |
2010-01-26 |
Amgen Inc. |
Molecules analogues au recepteur du tnf et ses utilisations
|
|
AU2001288999A1
(en)
*
|
2000-09-08 |
2002-03-22 |
Millennium Pharmaceuticals, Inc. |
38646, a guanine nucleotide exchange factor and uses therefor
|
|
US6391606B1
(en)
*
|
2000-09-14 |
2002-05-21 |
Pe Corporation |
Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
|
|
US6372468B1
(en)
|
2000-09-14 |
2002-04-16 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
JP2004531203A
(ja)
*
|
2000-10-05 |
2004-10-14 |
キュラジェン コーポレイション |
ヒトタンパク質、これらをコードするポリヌクレオチド、ならびにこれらの利用方法
|
|
AU2002220613A1
(en)
*
|
2000-10-11 |
2002-04-22 |
Bayer Aktiengesellschaft |
Regulation of human cyclophilin-type peptidyl-prolyl cis-trans isomerase
|
|
WO2002031132A2
(fr)
*
|
2000-10-11 |
2002-04-18 |
Millennium Pharmaceuticals, Inc. |
Nouvel element de la famille des phosphatases humaines a double specificite, appele 8843, et utilisation de ce dernier
|
|
WO2002031143A2
(fr)
*
|
2000-10-12 |
2002-04-18 |
The Texas A & M University System |
Sequences d'acides nucleiques codant des proteines cmg, proteines cmg et leurs procedes d'utilisation
|
|
AU2002215345A1
(en)
*
|
2000-10-13 |
2002-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
|
|
US6531297B2
(en)
*
|
2000-10-20 |
2003-03-11 |
Applera Corporation |
Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
|
|
EP1385861A2
(fr)
|
2000-10-25 |
2004-02-04 |
Diadexus, Inc. |
Compositions et techniques relatives a des genes et a des proteines specifiques du poumon
|
|
AU2002220668A1
(en)
*
|
2000-10-31 |
2002-05-15 |
Bayer Aktiengesellschaft |
Regulation of human glutathione-s-transferase
|
|
AU2002229011A1
(en)
*
|
2000-11-09 |
2002-05-21 |
Glaxo Group Limited |
Deaminase catalyzing the removal of the cyclopropyl moiety from abacavir-mp
|
|
WO2002040672A2
(fr)
|
2000-11-20 |
2002-05-23 |
Diadexus, Inc. |
Compositions et methodes relatives a des genes et des proteines specifiques aux seins
|
|
AU2001297765A1
(en)
*
|
2000-12-05 |
2002-10-21 |
Incyte Genomics, Inc. |
Ligases
|
|
ES2397627T3
(es)
|
2000-12-07 |
2013-03-08 |
Novartis Vaccines And Diagnostics, Inc. |
Retrovirus endógenos regulados por aumento en el cáncer de próstata
|
|
EP1339845A2
(fr)
|
2000-12-07 |
2003-09-03 |
ZymoGenetics, Inc. |
Proteine associee au complement adipocyte zacrp3x2
|
|
CA2439800A1
(fr)
*
|
2000-12-14 |
2002-06-20 |
Pe Corporation (Ny) |
Proteines kinases humaines isolees, molecules d'acide nucleique codant des proteines kinases humaines et utilisations associees
|
|
US20020142376A1
(en)
*
|
2000-12-20 |
2002-10-03 |
Gennady Merkulov |
Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
|
|
ES2265389T3
(es)
|
2000-12-22 |
2007-02-16 |
Bristol-Myers Squibb Company |
Proteina humana que contiene repeticiones ricas en leucina expresada predominantemente en el intestino delgado, hlrrsi1.
|
|
US7892730B2
(en)
|
2000-12-22 |
2011-02-22 |
Sagres Discovery, Inc. |
Compositions and methods for cancer
|
|
US6423521B1
(en)
|
2000-12-28 |
2002-07-23 |
Pe Corporation (Ny) |
Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
|
|
WO2002053591A1
(fr)
*
|
2000-12-30 |
2002-07-11 |
Lion Bioscience Ag |
Cofacteur de recepteur nucleaire mammalien cf12 et ses procedes d'utilisation
|
|
WO2002053754A2
(fr)
*
|
2001-01-08 |
2002-07-11 |
Lexicon Genetics Incorporated |
Nouvelle protease humaine et polynucleotides codant cette derniere
|
|
WO2002061046A2
(fr)
*
|
2001-01-30 |
2002-08-08 |
Regeneron Pharmaceuticals, Inc. |
Nouvelles molecules d'acide nucleique et polypeptidiques
|
|
CA2438571A1
(fr)
*
|
2001-02-12 |
2002-12-12 |
Curagen Corporation |
Proteines, polynucleotides codant pour lesdites proteines et methodes d'utilisation desdites proteines
|
|
EP1637601A3
(fr)
*
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Protéines , polynucléotides codant pour ces protéines et procédés d'utilisation
|
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
|
AU2002250143A1
(en)
*
|
2001-03-16 |
2002-10-03 |
Eli Lilly And Company |
Lp mammalian proteins; related reagents
|
|
US6913904B2
(en)
*
|
2001-03-27 |
2005-07-05 |
Applera Corporation |
Isolated human Ras-like proteins, nucleic acid molecules encoding these human Ras-like proteins, and uses thereof
|
|
AU2002303340A1
(en)
|
2001-04-10 |
2002-10-28 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
|
|
CA2442993C
(fr)
|
2001-04-10 |
2011-10-11 |
Agensys, Inc. |
Acide nucleique et proteine correspondante intitule 158p3d2 utiles dans le traitement et la detection du cancer
|
|
AU2002318112B2
(en)
|
2001-04-10 |
2007-12-06 |
Agensys, Inc. |
Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
|
WO2002086113A2
(fr)
*
|
2001-04-24 |
2002-10-31 |
Isis Innovation Ltd |
Enzyme et marqueur snp pour le depistage d'une maladie
|
|
KR20040015128A
(ko)
*
|
2001-04-24 |
2004-02-18 |
오츠카 세이야쿠 가부시키가이샤 |
크론병 항체 결합성 펩티드 및 크론병의 검사 방법
|
|
KR100781931B1
(ko)
*
|
2001-05-07 |
2007-12-04 |
시오노기세이야쿠가부시키가이샤 |
혈관신생 마커로서 사용되는 폴리펩티드 및 이의 ｄｎａ
|
|
WO2002090543A2
(fr)
*
|
2001-05-09 |
2002-11-14 |
Bayer Aktiengesellschaft |
Régulation de la protéine semblable à celle de type 2c de la phosphatase de l'acide phosphatidique humain
|
|
US7157558B2
(en)
|
2001-06-01 |
2007-01-02 |
Genentech, Inc. |
Polypeptide encoded by a polynucleotide overexpresses in tumors
|
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
US7235358B2
(en)
*
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
AU2002311535A1
(en)
*
|
2001-06-26 |
2003-01-08 |
Decode Genetics Ehf. |
Nucleic acids encoding protein kinases
|
|
GB2399087A
(en)
*
|
2001-08-02 |
2004-09-08 |
Aeomica Inc |
Human zinc finger containing gene MDZ7
|
|
EP1423415A4
(fr)
*
|
2001-08-17 |
2005-04-06 |
Incyte Genomics Inc |
Molecules de signalisation intercellulaire
|
|
US7270960B2
(en)
*
|
2001-08-29 |
2007-09-18 |
Pacific Northwest Research Institute |
Diagnosis of ovarian carcinomas
|
|
WO2003023063A1
(fr)
*
|
2001-09-07 |
2003-03-20 |
Sankyo Company, Limited |
Methode d'estimation du risque d'apparition de diabetes
|
|
WO2003040369A2
(fr)
*
|
2001-09-17 |
2003-05-15 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
|
WO2003025175A2
(fr)
*
|
2001-09-17 |
2003-03-27 |
Molecular Engines Laboratories |
Sequences impliquees dans les phenomenes de suppression tumorale, reversion tumorale, apoptose et/ou resistance aux virus et leur utilisation comme medicaments
|
|
JP2005534279A
(ja)
|
2001-09-28 |
2005-11-17 |
ブリガム ヤング ユニバーシティ |
新規なシクロオキシゲナーゼ変異体とその使用方法
|
|
US20040248132A1
(en)
|
2001-10-04 |
2004-12-09 |
Toshiyuki Sakai |
DR5 gene promoter and siah-1 gene promoter
|
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
|
WO2003031607A1
(fr)
*
|
2001-10-10 |
2003-04-17 |
Bayer Healthcare Ag |
Regulation de deshydrogenase/reductase des chaines courtes humaine
|
|
ATE364690T1
(de)
|
2001-11-09 |
2007-07-15 |
Proteologics Inc |
Posh nukleinsäure, polypeptide und darauf bezogene verfahren
|
|
AU2002365162A1
(en)
|
2001-11-14 |
2003-07-09 |
Northwestern University |
Self-assembly and mineralization of peptide-amphiphile nanofibers
|
|
JPWO2003044197A1
(ja)
*
|
2001-11-21 |
2005-03-24 |
独立行政法人科学技術振興機構 |
ハンチントン病遺伝子転写因子
|
|
US7151162B2
(en)
|
2001-12-06 |
2006-12-19 |
The University Of Children's Hospital Of Both Cantons Of Basel |
Nuclear protein
|
|
WO2003051911A2
(fr)
*
|
2001-12-19 |
2003-06-26 |
Genset S.A. |
Polypeptides et polynucleotides gmg-5 et utilisations de ceux-ci
|
|
JP2003245084A
(ja)
*
|
2001-12-20 |
2003-09-02 |
Morinaga Milk Ind Co Ltd |
脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
|
|
DE10163467A1
(de)
*
|
2001-12-21 |
2003-11-27 |
Axaron Bioscience Ag |
Protein 24B2 und zugrundliegende DNA-Sequenz
|
|
US6759222B2
(en)
|
2002-01-02 |
2004-07-06 |
Millennium Pharmaceuticals, Inc. |
14815, a human kinase family member and uses therefor
|
|
AU2003202543A1
(en)
*
|
2002-01-07 |
2003-07-24 |
Bayer Aktiengesellschaft |
Human phosphatidic acid phosphatase type 2-like protein
|
|
WO2003060109A2
(fr)
*
|
2002-01-15 |
2003-07-24 |
Bayer Healthcare Ag |
Regulation d'une subtilase humaine
|
|
WO2003059948A1
(fr)
*
|
2002-01-15 |
2003-07-24 |
Medigene Ag |
Gene-2 associe a la myocardiopathie dilatee (dcmag-2) : inducteur cytoplasmique du remodelage sarcomerique de cardiomyocytes
|
|
JPWO2003062429A1
(ja)
*
|
2002-01-23 |
2005-05-26 |
山之内製薬株式会社 |
新規セリンプロテアーゼ
|
|
WO2003070749A2
(fr)
|
2002-02-15 |
2003-08-28 |
Northwestern University |
Auto-assemblage de nanofibres amphiphiles peptidiques dans des conditions physiologiques
|
|
EP1338609A1
(fr)
*
|
2002-02-21 |
2003-08-27 |
MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln |
Un outre récepteur KDR et son utilisation
|
|
WO2003076645A2
(fr)
*
|
2002-03-05 |
2003-09-18 |
Applera Corporation |
Proteines transporteuses humaines isolees, molecules d'acide nucleique codant celles-ci, et utilisations associees
|
|
GB2388113A
(en)
*
|
2002-03-06 |
2003-11-05 |
Oxford Glycosciences |
B-cell malignancy-associated protein
|
|
EP2258872B1
(fr)
|
2002-03-13 |
2013-08-14 |
Genomic Health, Inc. |
Profilage de l'expression génétique dans des tissus de tumeurs prélevées par biopsie
|
|
JP3949111B2
(ja)
*
|
2002-03-19 |
2007-07-25 |
田辺製薬株式会社 |
新規ｇタンパク質共役型受容体およびその遺伝子
|
|
US7527935B2
(en)
|
2002-03-19 |
2009-05-05 |
Mitsubishi Tanabe Pharma Corporation |
G-protein coupled receptor having eicosanoid as ligand and gene thereof
|
|
GB0206684D0
(en)
*
|
2002-03-21 |
2002-05-01 |
Babraham Inst |
Novel proteins
|
|
US7193069B2
(en)
*
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
US7329502B2
(en)
|
2002-04-25 |
2008-02-12 |
The United States Of America As Represented By The Department Of Health And Human Services |
ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
|
|
JP2004041003A
(ja)
*
|
2002-05-17 |
2004-02-12 |
Takeda Chem Ind Ltd |
新規タンパク質、そのｄｎａおよびその用途
|
|
JP2005527614A
(ja)
|
2002-05-29 |
2005-09-15 |
デヴェロゲン アクチエンゲゼルシャフト フュア エントヴィックルングスビオローギッシェ フォルシュング |
膵臓特異性タンパク質
|
|
US7198899B2
(en)
|
2002-06-03 |
2007-04-03 |
Chiron Corporation |
Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
|
|
BRPI0311822B8
(pt)
*
|
2002-06-06 |
2021-05-25 |
Oncotherapy Science Inc |
composição farmacêutica para o tratamento de câncer
|
|
ATE545651T1
(de)
|
2002-06-13 |
2012-03-15 |
Novartis Vaccines & Diagnostic |
Vektoren zur expression von hml-2-polypeptiden
|
|
CA2493263A1
(fr)
*
|
2002-07-22 |
2004-01-29 |
Yamanouchi Pharmaceutical Co., Ltd. |
Nouveau gene associe a l'arthrite rhumatoide
|
|
AU2003256074B2
(en)
|
2002-08-14 |
2011-02-03 |
National Institute Of Advanced Industrial Science And Technology |
Novel N-acetylgalactosamine transferases and nucleic acids encoding the same
|
|
WO2004016733A2
(fr)
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers
|
|
AU2003235316A1
(en)
*
|
2002-08-23 |
2004-03-11 |
Japan Science And Technology Agency |
Human solid cancer antigen peptides, polynucleotides encoding the same and utilization thereof
|
|
EP1540014A2
(fr)
*
|
2002-08-27 |
2005-06-15 |
Epigenomics AG |
Procede et acides nucleiques servant a l'analyse de troubles lies a la proliferation des cellules mammaires
|
|
US7452969B2
(en)
|
2002-08-30 |
2008-11-18 |
Licentia Ltd |
Neurotrophic factor protein and uses thereof
|
|
ES2320443T3
(es)
|
2002-09-30 |
2009-05-22 |
Oncotherapy Science, Inc. |
Genes y polipeptidos relacionados con canceres pancreaticos humanos.
|
|
WO2004035823A2
(fr)
*
|
2002-10-17 |
2004-04-29 |
Evotec Neurosciences Gmbh |
Utilisation diagnostique et therapeutique des gene et proteine ensadin-0625 destinee a des maladies neurodegeneratives
|
|
AU2002952216A0
(en)
*
|
2002-10-23 |
2002-11-07 |
The Walter And Eliza Hall Institute Of Medical Research |
Novel therapeutic molecules
|
|
US7554021B2
(en)
|
2002-11-12 |
2009-06-30 |
Northwestern University |
Composition and method for self-assembly and mineralization of peptide amphiphiles
|
|
CA2506066A1
(fr)
|
2002-11-15 |
2004-06-03 |
Genomic Health, Inc. |
Etablissement de profils d'expressions genetique du cancer a recepteur de facteur de croissance epidermique positif
|
|
DE10254601A1
(de)
|
2002-11-22 |
2004-06-03 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
AU2003287764B2
(en)
*
|
2002-12-13 |
2010-01-21 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
|
AU2002953341A0
(en)
*
|
2002-12-13 |
2003-01-09 |
The Walter And Eliza Hall Institute Of Medical Research |
A novel phosphoprotein
|
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
|
US7326768B2
(en)
|
2003-02-05 |
2008-02-05 |
Juan Saus |
Goodpasture antigen-binding protein isoforms and protein misfolded-mediated disorders
|
|
EP1445614A1
(fr)
*
|
2003-02-06 |
2004-08-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Méthodes d'évaluation in vitro de l'état de progression d'un virus HIV chez un individu
|
|
US7074891B2
(en)
*
|
2003-02-07 |
2006-07-11 |
Posco |
Leukocyte stimulating peptides
|
|
ES2314378T3
(es)
|
2003-02-20 |
2009-03-16 |
Genomic Health, Inc. |
Uso de arn intronico para medir la expresion genica.
|
|
EP1600458A4
(fr)
*
|
2003-03-04 |
2006-10-25 |
Astellas Pharma Inc |
Nouveau gene associe a des conditions fibreuses
|
|
KR101106441B1
(ko)
|
2003-03-19 |
2012-01-18 |
바이오겐 아이덱 엠에이 인코포레이티드 |
노고 수용체 결합 단백질
|
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
|
ES2488845T5
(es)
|
2003-06-24 |
2017-07-11 |
Genomic Health, Inc. |
Predicción de la probabilidad de recidiva de cáncer
|
|
ES2651849T3
(es)
|
2003-07-10 |
2018-01-30 |
Genomic Health, Inc. |
Algoritmo del perfil de expresión y test para el pronóstico del cáncer
|
|
EP2311468B1
(fr)
|
2003-08-08 |
2014-01-15 |
Perseus Proteomics Inc. |
Gène surexprimé dans le cancer
|
|
US20050136434A1
(en)
*
|
2003-08-12 |
2005-06-23 |
Mai Xu |
Isolated heat-inducible cell surface protein and hyperthermia-based tumor immunotargeting therapy
|
|
US20070178458A1
(en)
*
|
2003-09-05 |
2007-08-02 |
O'brien Philippa |
Methods of diagnosis and prognosis of ovarian cancer II
|
|
WO2005026314A2
(fr)
*
|
2003-09-10 |
2005-03-24 |
Japan Science And Technology Agency |
Groupe de genes exprimes de facon differentielle dans des cellules de sang peripherique ainsi que procede de diagnostic et procede d'analyse mettant en oeuvre ce groupe
|
|
US8574596B2
(en)
*
|
2003-10-02 |
2013-11-05 |
Glaxosmithkline Biologicals, S.A. |
Pertussis antigens and use thereof in vaccination
|
|
CN1902227A
(zh)
|
2003-10-03 |
2007-01-24 |
布赖汉姆妇女医院 |
Tim－3配体及其方法
|
|
WO2005040791A2
(fr)
*
|
2003-10-21 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics et therapeutiques pour maladies liees au recepteur de peptides similaire a la somatostatine et a l'angiogenine (salpr)
|
|
US20050255560A1
(en)
*
|
2003-11-21 |
2005-11-17 |
Zeren Gao |
Ztnf11, a tumor necrosis factor
|
|
EP2314305A3
(fr)
*
|
2003-12-05 |
2011-08-10 |
Northwestern University |
Amphiphiles peptidiques a assemblage automatique et procédes associés d'administration de facteurs de croissance
|
|
WO2005064019A2
(fr)
|
2003-12-23 |
2005-07-14 |
Genomic Health, Inc. |
Amplification universelle d'arn fragmente
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
SI3296407T1
(sl)
|
2004-03-02 |
2019-09-30 |
The Johns Hopkins University |
Mutacije gena PIK3CA pri rakih pri ljudeh
|
|
TW200539890A
(en)
|
2004-03-12 |
2005-12-16 |
Brigham & Womens Hospital |
Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
|
|
WO2005090569A1
(fr)
*
|
2004-03-24 |
2005-09-29 |
The Council Of The Queensland Institute Of Medical Research |
Cancer et acides nucleiques et proteines de testicule vsm1 et vsm2, et leurs utilisations
|
|
CN1950397B
(zh)
*
|
2004-03-30 |
2012-05-16 |
Ns基因公司 |
生长因子NsG33的治疗用途
|
|
US7871769B2
(en)
|
2004-04-09 |
2011-01-18 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
|
DE102004024617A1
(de)
|
2004-05-18 |
2005-12-29 |
Ganymed Pharmaceuticals Ag |
Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
|
|
WO2005118832A2
(fr)
*
|
2004-06-01 |
2005-12-15 |
Bayer Healthcare Ag |
Agents diagnostiques et therapeutiques pour des maladies associees a une proteine de type kinase regulee par serum/glucocorticoide (sgkl)
|
|
PL1776136T3
(pl)
|
2004-06-24 |
2013-03-29 |
Biogen Ma Inc |
Leczenie stanów związanych z demielinizacją
|
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
|
JP4597132B2
(ja)
*
|
2004-08-05 |
2010-12-15 |
東亞合成株式会社 |
クローン病抗体エピトープペプチド及びクローン病の検査試薬
|
|
US7622251B2
(en)
|
2004-11-05 |
2009-11-24 |
Genomic Health, Inc. |
Molecular indicators of breast cancer prognosis and prediction of treatment response
|
|
WO2006052862A1
(fr)
|
2004-11-05 |
2006-05-18 |
Genomic Health, Inc. |
Prediction de reaction a la chimiotherapie au moyen de marqueurs d'expression genique
|
|
US8367805B2
(en)
|
2004-11-12 |
2013-02-05 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
BRPI0517837A
(pt)
|
2004-11-12 |
2008-10-21 |
Xencor Inc |
variantes fc com ligação alterada a fcrn
|
|
WO2006096614A2
(fr)
|
2005-03-04 |
2006-09-14 |
Northwestern University |
Epitopes angiogeniques de liaison a l'heparine, amphiphiles peptidiques, compositions auto-assemblees et procedes d'utilisation associes
|
|
WO2006120019A2
(fr)
*
|
2005-05-13 |
2006-11-16 |
Centre National De La Recherche Scientifique |
Utilisation de nouveau codage genique pour nouvel element de la famille mcm2-8 dans les compositions pharmaceutiques
|
|
JP2009502123A
(ja)
|
2005-07-08 |
2009-01-29 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Ｓｐ３５抗体およびその使用
|
|
WO2007014338A2
(fr)
*
|
2005-07-26 |
2007-02-01 |
Siemens Medical Solutions Diagnostics |
Polymorphismes de nucleotides uniques a susceptibilite par rapport a une maladie cardio-vasculaire
|
|
US8207128B2
(en)
*
|
2005-09-28 |
2012-06-26 |
Supadelixir Inc. |
Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
|
|
EP1790664A1
(fr)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Anticorps monoclonaux contre claudin-18 pour le traitement du cancer
|
|
DE602005023550D1
(de)
|
2005-12-14 |
2010-10-21 |
Licentia Ltd |
Verwendungen eines neurotrophischen Faktors
|
|
EP2044216A2
(fr)
*
|
2006-07-03 |
2009-04-08 |
Exonhit Therapeutics SA |
Produits de la transcription spécifiques de la prostate et leur utilisation pour des thérapeutiques et des diagnostics du cancer de la prostate
|
|
CA2662915A1
(fr)
*
|
2006-09-08 |
2008-03-13 |
Corixa Corporation |
Procedes, compositions, et kits de detection et de surveillance d'un cancer du colon
|
|
US8076295B2
(en)
|
2007-04-17 |
2011-12-13 |
Nanotope, Inc. |
Peptide amphiphiles having improved solubility and methods of using same
|
|
US8999634B2
(en)
*
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
|
GB0805159D0
(en)
*
|
2008-03-19 |
2008-04-23 |
Sancho Madrid David |
Immune modulation via C-type lectin
|
|
HUE027057T2
(en)
|
2007-07-27 |
2016-08-29 |
Immatics Biotechnologies Gmbh |
New immunogenic epitope for immunotherapy
|
|
US7863021B2
(en)
|
2007-09-05 |
2011-01-04 |
Celera Corporation |
Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
|
|
WO2009034661A1
(fr)
*
|
2007-09-12 |
2009-03-19 |
Toppan Printing Co., Ltd. |
Procédé de diagnostic et induction d'une résistance à un virus
|
|
US8354273B2
(en)
|
2007-10-17 |
2013-01-15 |
Universidad De Cordoba |
Isoforms of human somatostatin receptor type 5
|
|
EP4098661A1
(fr)
|
2007-12-26 |
2022-12-07 |
Xencor, Inc. |
Variantes fc avec liaison altérée en fcrn
|
|
GB0803352D0
(en)
|
2008-02-22 |
2008-04-02 |
Ntnu Technology Transfer As |
Oligopeptidic compounds and uses thereof
|
|
WO2009115612A1
(fr)
*
|
2008-03-21 |
2009-09-24 |
Universiteit Hasselt |
Biomarqueurs de la polyarthrite rhumatoïde
|
|
US8058406B2
(en)
|
2008-07-09 |
2011-11-15 |
Biogen Idec Ma Inc. |
Composition comprising antibodies to LINGO or fragments thereof
|
|
US8334264B2
(en)
|
2008-07-24 |
2012-12-18 |
NsGenee A/S |
Therapeutic use of a growth factor, METRNL
|
|
PL2172211T3
(pl)
|
2008-10-01 |
2015-05-29 |
Immatics Biotechnologies Gmbh |
Kompozycja związanych z guzem peptydów i związana z tym szczepionka przeciwrakowa do leczenia glejaka (GBM) i innych rodzajów raka
|
|
JP2012508586A
(ja)
|
2008-11-14 |
2012-04-12 |
ジェン−プローブ・インコーポレーテッド |
カンピロバクター属（Ｃａｍｐｙｌｏｂａｃｔｅｒ）核酸を検出するための組成物、キットおよび方法
|
|
WO2010062960A2
(fr)
|
2008-11-26 |
2010-06-03 |
Cedars-Sinai Medical Center |
Méthodes de détermination d'une réceptivité à une thérapie par anti-tnfα lors d’une maladie intestinale inflammatoire
|
|
US20110286924A1
(en)
*
|
2008-12-09 |
2011-11-24 |
Alethia Biotherapeutics Inc |
Novel human endogenous retroviral erv3 variant and uses thereof in the diagnosing ovarian cancer
|
|
AU2010236584A1
(en)
|
2009-04-13 |
2011-11-10 |
Northwestern University |
Novel peptide-based scaffolds for cartilage regeneration and methods for their use
|
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
EP2528615B1
(fr)
|
2010-01-27 |
2020-05-13 |
Massachusetts Institute of Technology |
Agents polypeptidiques techniques pour la neutralisation de la grippe à large spectre ciblée
|
|
TW202344270A
(zh)
|
2010-09-29 |
2023-11-16 |
美商艾澤西公司 |
與191p4d12蛋白結合之抗體藥物共軛物(adc)
|
|
EP2621512B1
(fr)
|
2010-10-01 |
2016-04-06 |
NsGene A/S |
Utilisation de la météorine pour le traitement de l'allodynie, de l'hyperalgésie, de la douleur spontanée et de la douleur illusionnelle
|
|
DK2651430T3
(en)
*
|
2010-12-14 |
2018-08-27 |
Hananja Ehf |
Biological activity of placental protein 13
|
|
CA2846511C
(fr)
|
2011-09-05 |
2021-07-13 |
Nsgene A/S |
Traitement d'allodynie, hyperalgie, douleur spontanee et douleur fantomeau moyen de cometin
|
|
AR088699A1
(es)
*
|
2011-11-09 |
2014-06-25 |
Sanofi Sa |
Diacilglicerol lipasa y usos de la misma
|
|
EP3489254B9
(fr)
|
2012-04-30 |
2022-12-21 |
Biocon Limited |
Protéines de fusion ciblées/immunomodulatrices et leurs procédés de fabrication
|
|
WO2013167153A1
(fr)
|
2012-05-09 |
2013-11-14 |
Ganymed Pharmaceuticals Ag |
Anticorps utiles dans le diagnostic du cancer
|
|
MX2014013950A
(es)
|
2012-05-14 |
2015-02-17 |
Biogen Idec Inc |
Antagonistas de proteina que interactua con el receptor nogo 2 que contiene repeticion rica en leucina y dominio de inmunoglobulina (lingo-2) para el tratamiento de afecciones que involucran neuronas motoras.
|
|
WO2013174404A1
(fr)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
|
JP6499079B2
(ja)
|
2012-11-13 |
2019-04-10 |
バイオエヌテック アーゲーＢｉｏＮＴｅｃｈ ＡＧ |
クローディンを発現するガン疾患を処置するための剤
|
|
WO2014127785A1
(fr)
|
2013-02-20 |
2014-08-28 |
Ganymed Pharmaceuticals Ag |
Polythérapie impliquant des anticorps dirigés contre la claudine 18,2 pour le traitement du cancer
|
|
US9023353B2
(en)
|
2013-03-13 |
2015-05-05 |
The Board Of Trustees Of The University Of Arkansas |
Anti-(+)—methamphetamine monoclonal antibodies
|
|
WO2014146672A1
(fr)
|
2013-03-18 |
2014-09-25 |
Ganymed Pharmaceuticals Ag |
Thérapie comprenant des anticorps dirigés contre cldn 18.2 pour le traitement du cancer
|
|
EP4285988A3
(fr)
|
2013-03-27 |
2024-03-06 |
Cedars-Sinai Medical Center |
Traitement de la fibrose par inhibition de tl1a
|
|
JP7019233B2
(ja)
|
2013-07-11 |
2022-02-15 |
モデルナティエックス インコーポレイテッド |
ＣＲＩＳＰＲ関連タンパク質をコードする合成ポリヌクレオチドおよび合成ｓｇＲＮＡを含む組成物ならびに使用方法
|
|
US10316083B2
(en)
|
2013-07-19 |
2019-06-11 |
Cedars-Sinai Medical Center |
Signature of TL1A (TNFSF15) signaling pathway
|
|
CN106163556B
(zh)
|
2013-09-25 |
2024-04-09 |
西托姆克斯治疗公司 |
基质金属蛋白酶底物和其它可切割部分及其使用方法
|
|
US20160367651A1
(en)
*
|
2013-10-01 |
2016-12-22 |
Mie University |
T cell inducing vaccine containing an interepitope sequence that promotes antigen presentation
|
|
WO2015116933A2
(fr)
|
2014-01-31 |
2015-08-06 |
Cytomx Therapeutics, Inc. |
Substrats pour matriptase et activateur u-plasminogène et autres fractions clivables, et leurs procédés d'utilisation
|
|
WO2016112270A1
(fr)
|
2015-01-08 |
2016-07-14 |
Biogen Ma Inc. |
Antagonistes de lingo-1 et leurs utilisations pour le traitement de troubles de démyélinisation
|
|
MA41374A
(fr)
|
2015-01-20 |
2017-11-28 |
Cytomx Therapeutics Inc |
Substrats clivables par métalloprotéase matricielle et clivables par sérine protéase et procédés d'utilisation de ceux-ci
|
|
WO2016201077A1
(fr)
*
|
2015-06-12 |
2016-12-15 |
Emory University |
Compositions de croissance et de survie pour des cellules capables de produire des anticorps et procédés associés
|
|
CN108138198B
(zh)
|
2015-09-04 |
2022-10-28 |
合成基因组股份有限公司 |
为提高的产率而改造的微生物
|
|
KR20220153109A
(ko)
|
2016-03-17 |
2022-11-17 |
세다르스-신나이 메디칼 센터 |
Rnaset2를 통한 염증성 장 질환의 진단 방법
|
|
WO2017172941A2
(fr)
*
|
2016-03-29 |
2017-10-05 |
Berz David |
Modulation de l'entretien structural de l'expression du chromosome-1
|
|
US9611297B1
(en)
|
2016-08-26 |
2017-04-04 |
Thrasos Therapeutics Inc. |
Compositions and methods for the treatment of cast nephropathy and related conditions
|
|
US11125757B2
(en)
|
2017-05-26 |
2021-09-21 |
Emory University |
Methods of culturing and characterizing antibody secreting cells
|
|
EP3508499A1
(fr)
|
2018-01-08 |
2019-07-10 |
iOmx Therapeutics AG |
Anticorps ciblant et d'autres modulateurs d'un gène d'immunoglobuline associé à une résistance contre des réponses immunitaires antitumorales et leurs utilisations
|
|
JP2022538688A
(ja)
|
2019-07-05 |
2022-09-05 |
イオックス セラピューティクス アーゲー |
ＩＧＳＦ１１（ＶＳＩＧ３）のＩｇＣ２に結合する抗体及びその使用
|
|
WO2021083958A1
(fr)
*
|
2019-10-29 |
2021-05-06 |
Specialites Pet Food |
Nouveaux peptides induisant la satiété
|
|
WO2021228999A1
(fr)
*
|
2020-05-12 |
2021-11-18 |
Institut Curie |
Épitopes néo-antigéniques associés à des mutations sf3b1
|
|
WO2022008027A1
(fr)
|
2020-07-06 |
2022-01-13 |
Iomx Therapeutics Ag |
Anticorps de liaison à l'igv d'igsf11 (vsig3) et leurs utilisations
|
|
WO2022158977A1
(fr)
*
|
2021-01-21 |
2022-07-28 |
Erasmus University Medical Center Rotterdam |
Lymphocytes t destinés à être utilisés en thérapie
|
|
EP4294403A1
(fr)
*
|
2021-02-18 |
2023-12-27 |
Beren Therapeutics P.B.C. |
Méthodes de traitement de l'hypercholestérolémie familiale hétérozygote et homozygote avec des cyclodextrines
|
|
WO2023225602A1
(fr)
*
|
2022-05-20 |
2023-11-23 |
Medikine, Inc. |
Polypeptides de liaison au récepteur de l'interleukine-18 et leurs utilisations
|